Sana Biotechnology, Inc.

NASDAQ:SANA

Biotechnology

Healthcare
$1.74 +1.23%

+$0.04 today

Market cap
$521.36M
Beta
2.16
P/E (TTM)
-3.5
EPS (TTM)
-$0.87
52W Low $2.58High $6.55

Volume 4.00M

Average 3.76M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$190.96M

FY 2025 · Annual

Net Income

-$244.17M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue000012.75M
Gross Profit0000(12.75M)
Gross Margin—————
Research & Development306.5M201M219.84M208.68M131.98M
Selling, General & Admin50.41M71.56M73.3M64.04M44.3M
Operating Expenses356.91M272.56M293.14M272.72M178.21M
Depreciation & Amortization11.07M15.63M24.56M17.39M12.75M
EBITDA(344.86M)(253.85M)(258.7M)(249.37M)(231.42M)
EBITDA Margin—————
Operating Income(356.91M)(272.56M)(293.14M)(272.72M)(190.96M)
Operating Margin—————
Interest Income676K3.76M9.94M10.47M3.85M
Interest Expense00000
Other Income / Expenses981K3.09M9.89M5.96M(53.21M)
Income Before Tax(355.93M)(269.48M)(283.26M)(266.76M)(244.17M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(355.93M)(269.48M)(283.26M)(266.76M)(244.17M)
Net Margin—————
EPS (Basic)(2.14)(1.43)(1.46)(1.16)(0.96)
EPS (Diluted)(2.14)(1.43)(1.46)(1.16)(0.96)
Weighted Avg Shares166.43M188.34M194.54M230.89M253.23M
Weighted Avg Shares (Diluted)166.43M188.34M194.54M230.89M253.23M

SANA Earnings Waterfall · TTM

NASDAQ:SANA · Revenue to Net Income

Key Ratios

EPS$-0.92
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$242.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.92, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 6, 2026
8-KCurrent reportSep 8, 2026

How much revenue does SANA generate?

Sana Biotechnology, Inc. (SANA) reported $0.00 of revenue in fiscal 2025.

Is SANA profitable?

Sana Biotechnology, Inc. (SANA) reported -$244.17M of net income.